Last Updated: May 11, 2026

Profile for Argentina Patent: 079127


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 079127

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Nov 23, 2030 Cubist Pharms Llc CUBICIN RF daptomycin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AR079127: Scope, Claims, and Patent Landscape

Last updated: February 21, 2026

Overview of Patent AR079127

Patent AR079127 covers a pharmaceutical compound or formulation in Argentina. Issued to secure exclusive rights for a specified period, it details specific claims that define the invention's scope and technical boundaries. The patent's legal status, scope, and relevance depend on its claims and the regional patent landscape.

Patent Scope and Claims

Claim Structure and Coverage

AR079127's claims are critical to understanding the scope. They delineate the invention's boundaries, focusing on the compound, formulation, or method of use. The typical structure involves:

  • Independent Claims: Define the core invention elements; likely specify the active compound, its structure, or formulation parameters.
  • Dependent Claims: Add specific features such as dosage forms, specific excipients, or treatment methods.

Example Claim Patterns:

  • A compound with a specific chemical structure.
  • A pharmaceutical composition comprising the compound with excipients.
  • A method of treating a disease with the composition.

Scope Analysis

The patent's claims likely cover:

  • A novel chemical entity or derivative.
  • A specific formulation with defined excipients.
  • A treatment method involving the compound.

The scope depends heavily on the breadth of the independent claims. Narrow claims protect specific embodiments but risk design-around; broad claims cover entire classes but face higher invalidity risks.

Key Claim Considerations:

  • Novelty: The compound or formulation must be new.
  • Inventive Step: Demonstrates a significant leap over prior art.
  • Industrial Applicability: Suitable for production and therapeutic use.

Limitations and Potential Challenges

  • Prior Art: Existing patents or publications could limit scope if similar compounds or formulations exist.
  • Claim Language: overly broad claims risk invalidation; specific language strengthens enforceability.
  • Intervention Periods: In Argentina, third-party challenge periods influence enforceability.

Patent Landscape in Argentina

Regional Patent Environment

Argentina's patent system follows standards aligned with the Paris Convention and TRIPS Agreement. Patent examination focuses on novelty, inventive step, and industrial applicability.

Major Competitors & Similar Patents

  • Local patents on similar compounds or formulations.
  • Foreign patents filed via the Patent Cooperation Treaty (PCT), particularly from major pharmaceutical markets such as US, Europe, and Japan.

Notable Patent Families & Related Patents

  • Patents filing similar compounds in Latin America.
  • Patent families sharing common priority dates, indicating strategic geographical coverage.

Patent Trends & Key Players

  • Active filers in the Argentine pharmaceutical sector include multinational companies (e.g., Pfizer, Novartis) and local innovators.
  • Increasing filings for biologics and new chemical entities (NCEs).

Patent Validity & Duration

  • Patents granted in 2018-2020 typically have a 20-year term from the filing date.
  • Maintenance fees are enforced annually.

Implications for Industry

  • The patent's scope influences market exclusivity.
  • Broader claims restrict competitors more effectively but are harder to defend.
  • Patent challenges and oppositions impact enforceability.

Summary

AR079127's claims likely define a specific pharmaceutical compound or formulation with strategic claims involving the compound structure and therapeutic method. Its value depends on how comprehensively these claims cover the invention and the presence of similar prior art. The wider patent landscape includes domestic and international filings, with multinational pharmas actively protecting innovations in Argentina.


Key Takeaways

  • Precise claim drafting determines the scope and enforceability of AR079127.
  • The patent landscape in Argentina is active, with recent growth in biologics and chemical entities.
  • Competitors’ patent filings influence the strength and freedom-to-operate analysis.
  • Patent validity depends on ongoing maintenance and challenged validity, which can vary based on claim scope.
  • Strategic patent positioning involves balancing broad claims with defensibility against prior art.

Frequently Asked Questions

1. What is the typical scope of claims in a pharmaceutical patent like AR079127?
Claims usually cover the specific chemical structure, formulation components, and methods of application or treatment, aiming to protect core innovations while balancing breadth and validity.

2. How does the Argentine patent system handle patent challenges?
Third parties can challenge patents during opposition periods or via nullity actions post-grant, focusing on prior art and validity issues.

3. Can broad chemical compound claims be enforced in Argentina?
Yes, if they are well-supported technically and withstand validity challenges; overly broad claims risk invalidation if not sufficiently backed by data.

4. How does the patent landscape influence development strategies?
Understanding existing patents facilitates avoiding infringement, designing around claims, and identifying freedom-to-operate or licensing opportunities.

5. What factors determine a patent’s enforceability in Argentina?
Claims' clarity, novelty, inventive step, proper maintenance, and the absence of successful prior art challenges determine enforceability.


References

  1. Argentine Patent Office. (2022). Patent guidelines and procedures for pharmaceutical inventions.
  2. World Intellectual Property Organization. (2020). Patent landscape report on Latin America.
  3. TRIPS Agreement. (1994). WTO.
  4. Patent Cooperation Treaty. (2023). PCT Applicant’s Guide.
  5. European Patent Office. (2021). Patent Search and Examination Process.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.